Genscript Biotech Corp (STU:G51)
€ 1.39 0.03 (2.21%) Market Cap: 3.05 Bil Enterprise Value: 1.74 Bil PE Ratio: 0 PB Ratio: 2.62 GF Score: 72/100

Full Year 2021 Genscript Biotech Corp Earnings Call Transcript

Mar 20, 2022 / 11:00PM GMT
Operator

Good day everyone. And thank you for standing by. Welcome to 2021 GenScript Biotech Annual Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I'd like to turn the call over to your first speaker today, Mr. Shiniu Wei. Please go ahead.

Shiniu Wei
GenScript Biotech Corporation - CFO

Thank you, Operator. Good morning everyone. Welcome. I'm Shiniu Wei, CFO at GenScript. We also have the following management team members attending today's call. Mr. Robin Meng, Chairman of the Board; Dr. Patrick Liu, Rotating CEO of GenScript; Dr. Ying Huang, CEO and CFO of Legend Biotech; Dr. Brian Min, CEO of GenScript ProBio; Dr. Ray Chen, President of GenScript Life Science Group; and Dr. [Aishi Bei], General Manager of Bestzyme.

Before we begin I'd like to remind everyone that on today's call we will be making forward-looking statements about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts which may constitute forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot